Pharmaceutical Market Access, Pricing and Reimbursement 2016 Europe

Pharmaceutical Market Access, Pricing and Reimbursement 2016 Europe is a conference dedicated to top tier government, hospitals, pharmaceuticals, bio-pharmaceuticals and non-profit organizations.

Key Topics

• Early Market Access of Health Technologies: The implications.
• Market Access strategies: How can we maximize our strategies?
• Emerging Markets: What knowledge, strategies and resources will be needed to maximize pricing and access and hurdles faced.
• Challenges & Opportunities in pharma pricing, reimbursement and market access: Changing market trends and influences
• Patient Access: How can this continue to improve?
• Pricing & Reimbursement: for Orphan Drugs and Biosimilars
• International Collaboration: Where do we agree and differ?
• Data Collection & Management: Using Real World Evidence and Patient Reported Outcomes for pricing and access
• Looking to the Future: What lies ahead?

Who should Attend

Attendees involved or interested in:

• Pricing and Reimbursement
• Market Access
• Health Economics and Outcomes Research
• Patient Outcomes
• Data Management/ Analysis
• Payer Relations/ Evidence
• Public/ Government Affairs
• Regulatory Affairs
• Payer, HTA Officials and Physicians